Reports

Sale

Hepatitis E Diagnostic Tests Market

Global Hepatitis E Diagnostic Tests Market Share, Size, Analysis, Growth, Report, Forecast: By Test Type: ELISA HEV IgM Test, ELISA HEV IgG Test, RT-PCR Test; By End-Use: Hospitals, Diagnostic Centres, Others; Regional Analysis; Market Dynamics: SWOT Analysis; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032

Global Hepatitis E Diagnostic Tests Market Outlook

The global hepatitis E diagnostic tests market size reached a value of approximately USD 65.4 billion in 2023. The market is further expected to grow at a CAGR of 4.5% between 2024 and 2032, reaching a value of USD 84.7 billion by 2032.

 

hepatitis e diagnostic tests market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Key Trends in the Market

Hepatitis E is a condition in which the liver becomes inflamed as a result of an infection caused by the Hepatitis E Virus (HEV). Typically, HEV is transmitted through faecal-oral contamination, most often by drinking water contaminated by faecal matter. The diagnostic tests for hepatitis E are based on the detection of anti-HEV immunoglobulins.

 

  • According to the hepatitis E diagnostic tests market analysis, the key trends propelling the growth of the market includes shift towards molecular diagnostics from conventional testing methods. Due to the increase in accuracy and decrease in time required to generate results, the application of molecular diagnostics has significantly increased in the market.
  • Growing awareness about the advantages of regularly testing for hepatitis E virus along with selection of right course of treatment in due time is propelling the growth of the market for hepatitis E diagnostic tests. This, in turn, is influencing the hepatitis E diagnostic tests market price across the globe.
  • Increasing modernisations and technological advancements in the healthcare sector coupled with growing research and development activities by the key players are positively impacting the growth of the market across the globe. Rising geriatric population along with increasing cases of hepatitis E is another crucial trend in the market for hepatitis E diagnostic tests.

 

Market Analysis

 

hepatitis e diagnostic tests market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

On the basis of test type, the market is segmented into ELISA HEV IgM test, ELISA HEV IgG test, and RT-PCR test. Based on end-use, the market is divided into hospitals, and diagnostic centres, among others. By region, the market is classified into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global hepatitis E diagnostic tests market, covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.

 

  • MP Biomedicals, LLC
  • F. Hoffmann-La Roche Ltd
  • Altona Diagnostics GmbH
  • AccuBioTech Co., Ltd.
  • Dia.Pro Diagnostic Bioprobes s.r.l
  • Beijing Wantai
  • Fortress Diagnostics
  • Mikrogen GmbH.
  • Primerdesign Ltd
  • Gold Standard Diagnostics
  • Others

 

Market Share by End-Use

According to the hepatitis E diagnostic tests market research, hospitals are expected to account for a major portion of the market for hepatitis E diagnostic tests over the forecast period. This is due to the fact that hospitals are able to integrate diagnostics and treatment with care coordination, which in turn results in faster recovery of the patient. Hospitals are also able to identify potential signs of the virus at an earlier stage, resulting in greater usage of hepatitis E diagnostic tests. Additionally, hospitals are able to provide services such as language assistance, dietary support, and post treatment care, which is contributing towards the growth of the segment in the market for hepatitis E diagnostic tests.

 

Market Share by Region

In terms of regions, the Asia Pacific holds a significant hepatitis E diagnostic tests market share owing to the heightened prevalence of hepatitis E in East and South Asia. The hyper-endemicity of the condition in the region, worsened by lack of safe drinking water and poor sanitation facilities, are resulting in an increased demand for hepatitis E diagnostic tests. Increasing awareness hepatitis E and overall improved healthcare knowledge are resulting in more people opting for diagnostic tests at earlier signs of symptoms. Heightened population density further increases the risk of spread of hepatitis E, particularly in regions with lack of adequate sanitation. Investments of governments in the region to improve healthcare infrastructure and diagnose and treat prevalent conditions at a faster pace are further supporting the market for hepatitis E diagnostic tests in the Asia Pacific.

 

hepatitis e diagnostic tests market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Competitive Landscape

MP Biomedicals, LLC is a biotechnology research company that was established in 1959 and is headquartered in California, United States. Their dedicated team of researchers and scientists is on a quest for ground-breaking discoveries to improve lives and create a better world. The company sells and manufactures over 55,000 products across the globe.

 

F. Hoffmann-La Roche Ltd is a healthcare company based in Base, Switzerland, that was founded in 1896. The two major divisions of this multinational company are diagnostics and pharmaceuticals, with a wide range of focus areas including cardiometabolic diseases, haematology, infectious diseases, inflammatory bowel diseases, neuroscience, oncology, ophthalmology, rare diseases, and women’s health.

 

Altona Diagnostics GmbH is a medical diagnostic company that was established in 2007 and is headquartered in Hamburg, Germany. They are involved in the development and manufacture of in-vitro diagnostic tests for detection of viruses, parasites, and bacteria. With over 40 distribution partners, the company’s offerings include instruments and equipment, reagents, and products.

 

Other market players include AccuBioTech Co., Ltd., Dia.Pro Diagnostic Bioprobes s.r.l, Beijing Wantai, Fortress Diagnostics, Mikrogen GmbH., Primerdesign Ltd, and Gold Standard Diagnostics, among others.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Test Type
  • End-Use
  • Region
Breakup by Test Type
  • ELISA HEV IgM Test
  • ELISA HEV IgG Test
  • RT-PCR Test
Breakup by End-Use
  • Hospitals
  • Diagnostic Centres
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • MP Biomedicals, LLC
  • F. Hoffmann-La Roche Ltd
  • Altona Diagnostics GmbH
  • AccuBioTech Co., Ltd.
  • Dia.Pro Diagnostic Bioprobes s.r.l
  • Beijing Wantai
  • Fortress Diagnostics
  • Mikrogen GmbH.
  • Primerdesign Ltd
  • Gold Standard Diagnostics
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Hepatitis E Diagnostic Tests Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Hepatitis E Diagnostic Tests Historical Market (2018-2023) 
    8.3    Global Hepatitis E Diagnostic Tests Market Forecast (2024-2032)
    8.4    Global Hepatitis E Diagnostic Tests Market by Test Type
        8.4.1    ELISA HEV IgM Test
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2023)
            8.4.1.3    Forecast Trend (2024-2032)
        8.4.2    ELISA HEV IgG Test
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2023)
            8.4.2.3    Forecast Trend (2024-2032)
        8.4.3    RT-PCR Test
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2023)
            8.4.3.3    Forecast Trend (2024-2032)
    8.5    Global Hepatitis E Diagnostic Tests Market by End-Use
        8.5.1    Hospitals
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2023)
            8.5.1.3    Forecast Trend (2024-2032)
        8.5.2    Diagnostic Centres
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2023)
            8.5.2.3    Forecast Trend (2024-2032)
        8.5.3    Others  
    8.6    Global Hepatitis E Diagnostic Tests Market by Region
        8.6.1    North America
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2023) 
            8.6.1.3    Forecast Trend (2024-2032)
        8.6.2    Europe
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2023) 
            8.6.2.3    Forecast Trend (2024-2032)
        8.6.3    Asia Pacific
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2023) 
            8.6.3.3    Forecast Trend (2024-2032)
        8.6.4    Latin America
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2018-2023) 
            8.6.4.3    Forecast Trend (2024-2032)
        8.6.5    Middle East and Africa
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2018-2023) 
            8.6.5.3    Forecast Trend (2024-2032)
9    North America Hepatitis E Diagnostic Tests Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2023) 
        9.1.3    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2023) 
        9.2.3    Forecast Trend (2024-2032)
10    Europe Hepatitis E Diagnostic Tests Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2023) 
        10.1.3    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2023) 
        10.2.3    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2023) 
        10.3.3    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2023) 
        10.4.3    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Hepatitis E Diagnostic Tests Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2023) 
        11.1.3    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2023) 
        11.2.3    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2023) 
        11.3.3    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2023) 
        11.4.3    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2023) 
        11.5.3    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Hepatitis E Diagnostic Tests Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2023) 
        12.1.3    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2023) 
        12.2.3    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2023) 
        12.3.3    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Hepatitis E Diagnostic Tests Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2023) 
        13.1.3    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2023) 
        13.2.3    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2023) 
        13.3.3    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2023) 
        13.4.3    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis  
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price  
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    MP Biomedicals, LLC
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    F. Hoffmann-La Roche Ltd
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Altona Diagnostics GmbH
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    AccuBioTech Co., Ltd.
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Dia.Pro Diagnostic Bioprobes s.r.l
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Beijing Wantai
            15.2.6.1    Company Overview
            15.2.6.2    Product Portfolio
            15.2.6.3    Demographic Reach and Achievements
            15.2.6.4    Certifications
        15.2.7    Fortress Diagnostics
            15.2.7.1    Company Overview
            15.2.7.2    Product Portfolio
            15.2.7.3    Demographic Reach and Achievements
            15.2.7.4    Certifications
        15.2.8    Mikrogen GmbH.
            15.2.8.1    Company Overview
            15.2.8.2    Product Portfolio
            15.2.8.3    Demographic Reach and Achievements
            15.2.8.4    Certifications
        15.2.9    Primerdesign Ltd
            15.2.9.1    Company Overview
            15.2.9.2    Product Portfolio
            15.2.9.3    Demographic Reach and Achievements
            15.2.9.4    Certifications
        15.2.10    Gold Standard Diagnostics
            15.2.10.1    Company Overview
            15.2.10.2    Product Portfolio
            15.2.10.3    Demographic Reach and Achievements
            15.2.10.4    Certifications
        15.2.11    Others  
16    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Hepatitis E Diagnostic Tests Market: Key Industry Highlights, 2018 and 2032 
2.    Global Hepatitis E Diagnostic Tests Historical Market: Breakup by Test Type (USD Million), 2018-2023
3.    Global Hepatitis E Diagnostic Tests Market Forecast: Breakup by Test Type (USD Million), 2024-2032
4.    Global Hepatitis E Diagnostic Tests Historical Market: Breakup by End-Use (USD Million), 2018-2023
5.    Global Hepatitis E Diagnostic Tests Market Forecast: Breakup by End-Use (USD Million), 2024-2032
6.    Global Hepatitis E Diagnostic Tests Historical Market: Breakup by Region (USD Million), 2018-2023
7.    Global Hepatitis E Diagnostic Tests Market Forecast: Breakup by Region (USD Million), 2024-2032
8.    North America Hepatitis E Diagnostic Tests Historical Market: Breakup by Country (USD Million), 2018-2023
9.    North America Hepatitis E Diagnostic Tests Market Forecast: Breakup by Country (USD Million), 2024-2032
10.    Europe Hepatitis E Diagnostic Tests Historical Market: Breakup by Country (USD Million), 2018-2023
11.    Europe Hepatitis E Diagnostic Tests Market Forecast: Breakup by Country (USD Million), 2024-2032
12.    Asia Pacific Hepatitis E Diagnostic Tests Historical Market: Breakup by Country (USD Million), 2018-2023
13.    Asia Pacific Hepatitis E Diagnostic Tests Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Latin America Hepatitis E Diagnostic Tests Historical Market: Breakup by Country (USD Million), 2018-2023
15.    Latin America Hepatitis E Diagnostic Tests Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Middle East and Africa Hepatitis E Diagnostic Tests Historical Market: Breakup by Country (USD Million), 2018-2023
17.    Middle East and Africa Hepatitis E Diagnostic Tests Market Forecast: Breakup by Country (USD Million), 2024-2032
18.    Global Hepatitis E Diagnostic Tests Market Structure

Key Questions Answered in the Report

The market size for hepatitis E diagnostic tests reached a value of approximately USD 65.4 billion in 2023.

The market for hepatitis E diagnostic tests is expected to grow at a CAGR of 4.5% between 2024 and 2032.

The market for hepatitis E diagnostic tests is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 84.7 billion by 2032.

The major market drivers include increasing prevalence of hepatitis E, improved availability of hepatitis E diagnostic tests, and increasing initiatives by various government across the globe to increase the knowledge about hepatitis E.

The key hepatitis E diagnostic tests market trends include shift towards molecular diagnostics from conventional testing methods, growing awareness about the advantages of regularly testing for hepatitis E virus, and increasing technological advancements.

The various end-uses in the market are hospitals, and diagnostic centres, among others.

The symptoms of hepatitis E can include lack of appetite, fatigue, jaundice, nausea, and stomach pain, however, in many cases, particularly young children, hepatitis E can be asymptomatic.

The significant test types in the market are ELISA HEV IgM test, ELISA HEV IgG test, and RT-PCR test.

The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The key players in the global hepatitis E diagnostic tests market are MP Biomedicals, LLC, F. Hoffmann-La Roche Ltd, Altona Diagnostics GmbH, AccuBioTech Co., Ltd., Dia.Pro Diagnostic Bioprobes s.r.l, Beijing Wantai, Fortress Diagnostics, Mikrogen GmbH., Primerdesign Ltd, and Gold Standard Diagnostics, among others.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER